UrWay Health vs Hims: Compare GLP-1 Programs & Pricing
Side-by-side UrWay Health and Hims: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
UrWay Health and Hims are two telehealth companies that offer GLP-1–based weight management options, including semaglutide and tirzepatide formulations supplied through partnered pharmacies. This comparison highlights medical workflow, pricing transparency, membership requirements, safety, and patient experience to help you choose.
UrWay Health vs Hims: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| UrWay Health | Not publicly listed | Not publicly listed | (Code: not listed) | — No |
| Hims | Not publicly listed | Not publicly listed | (Code: not listed) | — Not specified |
UrWay Health vs Hims: Medical Process & Accessibility
UrWay Health typically emphasizes a streamlined telehealth intake: a clinical questionnaire, medical record review, and clinician approval for GLP-1 prescriptions. Hims likewise uses online intake but often highlights structured follow-ups and dose adjustment support. Both require clinicians to evaluate eligibility and contraindications before prescribing.
UrWay Health vs Hims: Pricing Comparison
Neither UrWay Health nor Hims publicly lists consistent, industry-standard starting prices for compounded semaglutide or tirzepatide on their marketing pages at the time of writing. Pricing can vary by dosage, pharmacy fulfillment, and whether branded products or compounded alternatives are provided. Because both providers rely on pharmacy partners and individualized prescriptions, initial cost estimates are typically provided after intake or in the provider’s checkout flow.
For transparency: where a lower published price exists, we would bold it here for clarity. In this case both providers show “Not publicly listed” for semaglutide and tirzepatide starting prices on their consumer pages, so patients should request a formal quote or cart total before confirming treatment.
UrWay Health vs Hims: Clinical Oversight & Support
Both platforms operate under U.S. state licensure rules for telemedicine: licensed clinicians review medical history, evaluate for contraindications (e.g., personal/family history of medullary thyroid carcinoma, pancreatitis risk factors), and determine suitability for GLP-1 therapy. They also provide prescription routing to partnered pharmacies and offer clinician messaging or scheduled follow-ups to monitor response and adverse effects.
UrWay Health vs Hims: Medication Quality & Safety
These telehealth providers may offer compounded versions of semaglutide or tirzepatide via accredited U.S. pharmacies. Compounded prescriptions are legal when prescribed by qualified clinicians but are not the same as FDA-approved branded products (for example Wegovy® or Mounjaro®). Patients should discuss formulation, source pharmacy accreditation, and expected monitoring protocols with their clinician.
Verify UrWay Health Pharmacy Partners
UrWay Health vs Hims: Customer Experience
Patient reports often emphasize two trade-offs: UrWay Health is commonly chosen for affordability and a fast onboarding experience, while Hims is frequently noted for its app-driven follow-up and clinical outreach. Shipping timelines can vary, but many users report receiving medication within a week after approval.
UrWay Health vs Hims: Final Verdict
Choose UrWay Health if your priority is a quick, low-friction enrollment and you plan to obtain pricing after intake. Choose Hims if you want a platform with integrated follow-up tools and emphasis on patient communication. Both providers follow telehealth standards and require clinician evaluation prior to prescribing GLP-1 therapies.
Join UrWay Health
Get Started with Hims
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Prices and promotions change and may not be publicly listed; always request a written estimate. GLP1Talks & ExploreProviders may receive referral compensation. Consult a licensed clinician before beginning any GLP‑1 or weight management treatment. FDA-approved brand names referenced are registered trademarks of their respective manufacturers.